KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 102 filers reported holding KRYSTAL BIOTECH INC in Q3 2020. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,395,805 | +5.7% | 520,637 | +7.0% | 0.02% | +11.1% |
| Q2 2023 | $57,124,745 | +54.4% | 486,597 | +5.3% | 0.02% | +50.0% |
| Q1 2023 | $36,994,210 | +119851.4% | 462,090 | +18.7% | 0.01% | +33.3% |
| Q4 2022 | $30,841 | -99.9% | 389,285 | +8.5% | 0.01% | -10.0% |
| Q3 2022 | $25,012,000 | +38.1% | 358,837 | +30.0% | 0.01% | +66.7% |
| Q2 2022 | $18,116,000 | +3.7% | 275,923 | +5.1% | 0.01% | +20.0% |
| Q1 2022 | $17,465,000 | +65.7% | 262,463 | +74.2% | 0.01% | +66.7% |
| Q4 2021 | $10,538,000 | +23.2% | 150,641 | -8.1% | 0.00% | 0.0% |
| Q3 2021 | $8,557,000 | -41.1% | 163,864 | -23.3% | 0.00% | -40.0% |
| Q2 2021 | $14,533,000 | +29.9% | 213,712 | +47.1% | 0.01% | +25.0% |
| Q1 2021 | $11,192,000 | +172.9% | 145,332 | +112.6% | 0.00% | +300.0% |
| Q4 2020 | $4,101,000 | +103.0% | 68,344 | +45.6% | 0.00% | 0.0% |
| Q3 2020 | $2,020,000 | +36.0% | 46,954 | +30.9% | 0.00% | 0.0% |
| Q2 2020 | $1,485,000 | +199.4% | 35,858 | +151.3% | 0.00% | – |
| Q3 2019 | $496,000 | – | 14,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $31,079,000 | 9.72% |
| Knoll Capital Management, LLC | 120,212 | $4,174,000 | 3.82% |
| S Squared Technology, LLC | 67,533 | $2,345,000 | 2.07% |
| Redmile Group, LLC | 1,078,300 | $37,444,000 | 1.25% |
| EAM Investors, LLC | 87,914 | $3,053,000 | 0.81% |
| Consonance Capital Management LP | 224,090 | $7,782,000 | 0.77% |
| EAM Global Investors LLC | 41,329 | $1,435,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 117,625 | $4,085,000 | 0.63% |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | 28,000 | $972,000 | 0.62% |
| Atika Capital Management LLC | 58,319 | $2,026,000 | 0.43% |